BioSpace News Archive

The U.S. Biotechnology & Pharmaceutical Services Outsourcing market size was valued at US$ 4.1 billion in 2021 and is expected to hit US$ 6.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030.

According to Report Study, the U.S. Clinical Trials market size was valued at US$ 23.1 billion in 2021 and is expected to hit US$ 35.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.2% from 2022 to 2030.

According to Nova one advisor, the U.S. Telehealth market size was valued at US$ 23.8 billion in 2021 and is expected to hit US$ 309.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 45.1% from 2022 to 2030.

AbCellera (Nasdaq: ABCL) today announced that Eli Lilly and Company (Lilly) has entered into a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab, the second antibody developed through AbCellera’s collaboration with Lilly, for approximately $275 million.

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, announced today it will present a poster at the upcoming International Neuroscience Conference of the Federation of the European Neuroscience Societies (FENS).

Bolden Therapeutics, Inc. announced being awarded a Small Business Innovative Research grant for $497,500 from the National Institute on Aging of the National Institutes of Health.

A New Business Strategy report released by Data Bridge Market Research with the title Global Active Pharmaceutical Ingredients (API) Market Study Forecast till 2028.

Eurofins DiscoverX announced the official opening of its new China biotechnology office in Shanghai.

On Friday, U.S. Senators Chris Van Hollen (D-MD) and Ben Ray Lujan (D-NM), and U.S. Reps. Don Beyer (D-VA), and Kim Schrier (D-WA) introduced legislation, the Improving Diagnosis in Medicine Act of 2022 (H.R.8172/S.4468) to focus federal health agencies on tackling the root causes of diagnostic error.

StarAligners, Inc, a leader and innovator of clear aligners, orthodontic products, and solutions, announces the launch of Illumina™, an innovative orthodontic product new to the market.